Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KRAB domain-containing protein 4 (KRBOX4, ZNF673) belongs to the family of KRAB-Zinc Finger Proteins (KRAB-ZFPs), which are among the largest groups of transcriptional repressors in vertebrates[1][3][5]. KRAB-ZFPs contain an N-terminal Krüppel-associated box (KRAB) domain and multiple C2H2-type zinc finger motifs, enabling sequence-specific DNA binding and recruitment of corepressors such as KAP1/TRIM28 to promote transcriptional repression via heterochromatin formation[1][2][3][5]. While KRAB domain-containing proteins are important for transcriptional regulation, cell development, and other fundamental processes, KRAB domain-containing protein 4 (KRBOX4/ZNF673) itself is not recognized as a validated therapeutic target or disease biomarker; its specific biological or pathological roles remain largely uncharacterized[4]. The functional activities attributed here are inferred from the broader KRAB-ZFP family rather than direct evidence for KRBOX4. Additional Notes: - The submitted abbreviation “KRABD4” is non-standard and not found in authoritative databases. - KRBOX4/ZNF673 is *not* a canonical therapeutic target (e.g., not a receptor, enzyme, transporter)[4]. - There is **no known drug, biomarker, or safety concern** specifically associated with KRBOX4/ZNF673. - Functional details largely reflect KRAB-ZFP properties as a group, not specific data for this protein[1][3][5]. If you require information on the KRAB domain itself or on KRAB domain-containing protein families, rather than this specific gene/protein, please clarify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KRAB domain-containing protein 4 (KRBOX4).